Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05025241 Active, not recruiting - Clinical trials for Phelan-McDermid Syndrome

An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001)

PMS-001
Start date: August 8, 2022
Phase: Phase 2
Study type: Interventional

A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Phelan-McDermid Syndrome.

NCT ID: NCT05024435 Completed - Neonatology Clinical Trials

Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The overall aim of this study is to determine the differences between two surfactant administration catheters in preterm infants.

NCT ID: NCT05024110 Completed - Clinical trials for Vitamin D Deficiency

Effect of Exercise Intensity on Vitamin D

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

Children with Down's syndrome (DS) are more liable to vitamin D deficiency. Treating this deficiency with supplements is associated with the risk of intoxication due to increased intestinal absorption or decreased vitamin D metabolism. The aim of the study was to compare the effect of two exercise intensities on the modulation of vitamin D and Parathormone (PTH) levels in children with DS.

NCT ID: NCT05023603 Completed - Clinical trials for Carpal Tunnel Syndrome

Social and Cognitive Factors in Carpal Tunnel Syndrome

Start date: October 25, 2021
Phase:
Study type: Observational [Patient Registry]

Carpal tunnel syndrome (CTS) is a compressive peripheral neuropathy, characterized by pain, tingling sensation and paresthesia in the territory of the median nerve, symptoms modulated by psychosocial factors (eg, catastrophic thinking, depression, anxiety). The objective of the study is to determine those psychological and social components that influence the symptoms and function of patients with CTS. An observational cross-sectional design will be performed in patients with CTS. The patients will be selected consecutively in two hospitals of the South East Metropolitan Health Service (Santiago, Chile). The study variables will include: Perception of pain using the Visual Analogue Scale (VAS), the extent of symptoms will be evaluated using the Katz diagram; Functional assessment using the abbreviated version of the Disabilities of the Arm, Shoulder and Hand Questionnaire (QuickDASH); Catastrophic thinking as a response to pain using the Pain Catastrophizing Scale (PCS), fear of movement using the Tampa Scale for Kinesiophobia (TSK-11), and emotional state was assessed using the Hospital Anxiety and Depression Scale (HADS). Both are valid and reliable measures used to evaluate the influence of psychosocial factors in patients with CTS. Individual subject factors including duration of symptoms, type of work (desk / non-desk), BMI, age, gender, educational level and economic income will be collected through an interview process.

NCT ID: NCT05023382 Recruiting - Clinical trials for Short Bowel Syndrome

A Study of Teduglutide in Japanese People With Short Bowel Syndrome

Start date: September 1, 2021
Phase:
Study type: Observational

The main aims of this study are to check for side effects from treatment with teduglutide (Revestive) and how well teduglutide controls symptoms of short bowel syndrome. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. During the study, participants with short bowel syndrome will receive an injection of teduglutide just under the skin (subcutaneous) according to their clinic's standard practice. The study doctors will check for side effects from teduglutide for 36 months.

NCT ID: NCT05022888 Not yet recruiting - Clinical trials for Myofascial Pain Syndrome

Near-Infrared Spectroscopy in Myofascial Pain Syndrome

Start date: August 23, 2021
Phase: N/A
Study type: Interventional

Myofascial pain syndrome is a regional pain syndrome accompanied by sensorial, motor and autonomic symptoms . myofascial trigger points are most frequently detected in the upper trapezius, levator scapula, and axial postural muscles such as rhomboid major. Myofascial pain syndrome is characterized by active myofascial trigger points in the form of focal hyperirritable nodules palpated in the tight band of the muscle . Alteration of tissue vascularization could limit or prevent th may cause adhesions, contractures and pain. As a result of decreased blood flow, tissue oxygenation may decrease.

NCT ID: NCT05022303 Terminated - Covid19 Clinical Trials

AT1001 for the Treatment of COVID-19 Related MIS-C

Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to evaluate the efficacy and safety of AT1001 versus placebo in pediatric patients with SARS-CoV-2 infection who experience early signs of MIS-C and are at high risk of progression. AT1001 10 μg/kg/dose up to 500 μg/dose (rounded to the nearest 50 μg) or matching placebo will be administered orally four times a day (QID) to the standard of care for MIS-C.

NCT ID: NCT05021861 Not yet recruiting - Periodontitis Clinical Trials

Evaluation of Periodontal Status and hsCRP Levels in Females With PCOS on CPA/EE Combination Drug Regimen

Start date: November 2021
Phase:
Study type: Observational

PCOS is a widely reported condition among young female population and anti-androgen agents are increasingly being used as part of the medical management of such cases. However, Clinical studies have reported higher prevalence of gingival inflammation, loss of attachment and gingival enlargement in women taking hormone based oral contraceptives. Additionally, CPA has been reported to have an osteoclastic action. Therefore, it is necessary to explore whether these medications affect the periodontal condition of PCOS patients, who already are pre-disposed to systemic inflammation. Therefore, the present study aims to evaluate the periodontal status of female patients diagnosed with Polycystic Ovary syndrome on Cyproterone acetate/ethinyl estradiol combination regimen.

NCT ID: NCT05020782 Recruiting - Clinical trials for Antiphospholipid Syndrome

The BeLimumab Antiphospholipid Syndrome Trial (BLAST)

BLAST
Start date: June 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

AIM: The primary objective of the BeLimumab Antiphospholipid Syndrome Trial (BLAST) is to evaluate the safety and tolerability of belimumab for up to 24 months in patients with persistent aPL positivity and clinical features attributable to aPL that are resistant to warfarin and/or heparin.

NCT ID: NCT05019859 Completed - Metabolic Syndrome Clinical Trials

Effects of a Low Carb Diet on Erectile Function and Serem Testosterone in Men With Metabolic Syndrome

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Investigate if low carb diet could increase serum testosterone level in hypogonadic men